Dysregulated Expression of Cyclin D1 in Normal Human Mammary Epithelial Cells Inhibits All-trans-Retinoic Acid-Mediated G0/G1-Phase Arrest and Differentiationin Vitro
- 1 May 1999
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 249 (1) , 70-85
- https://doi.org/10.1006/excr.1999.4462
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Chemoprevention Trial of Contralateral Breast Cancer with Fenretinide. Rationale, Design, Methodology, Organization, Data Management, Statistics and AccrualTumori Journal, 1997
- Retinoids in Cancer ChemopreventionAnnals of the New York Academy of Sciences, 1995
- The retinoblastoma protein and cell cycle controlCell, 1995
- Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakiaJournal of Cellular Biochemistry, 1995
- Vitamin A, differentiation and cancerCurrent Opinion in Cell Biology, 1994
- The Retinoblastoma Protein: More than a Tumor SuppressorAnnual Review of Cell Biology, 1994
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- A Prospective Study of the Intake of Vitamins C, E, and A and the Risk of Breast CancerNew England Journal of Medicine, 1993
- Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cellsCell, 1992
- Creative blocks: cell-cycle checkpoints and feedback controlsNature, 1992